HSCA Comments to EPA on Proposal to Reduce Ethylene Oxide Emissions (EtO) from Commercial Sterilization Facilities and Proposed Interim Decision and Draft Risk Assessment Addendum for Ethylene Oxide
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Environmental Protection Agency (EPA) on ethylene oxide (EtO).
Please find comments regarding the proposed amendments to the National Emission Standards for Hazardous Air Pollutants (NESHAP) for the Commercial Sterilization Facilities source category here.
Please find comments regarding the proposed interim registration review decision and draft risk assessment addendum for ethylene oxide (EtO) here.
Lear MoreHSCA Response to FDA Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Draft Guidance
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to comment on the Food and Drug Administration’s (FDA) draft guidance, “Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Under Section 506C of the FD&C Act.”
Click here to read the full response.
Lear MoreHSCA ANNOUNCES INAUGURAL HEALTHCARE SUPPLY CHAIN LEADERSHIP SUMMIT
Washington, DC (May 9, 2023) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today announced the Supply Chain Leadership Summit, an event designed to foster greater collaboration between supply chain stakeholders. The three-day event, which takes place from October 3-5, 2023, will bring together leaders from across the healthcare supply chain to network, discuss best practices and current challenges, and evaluate strategies to build a more resilient supply chain.
Click here to read the full release.
Lear MoreHEALTHCARE SUPPLY CHAIN ASSOCIATION GROWS MEMBERSHIP, ADDS CAPSTONE HEALTH ALLIANCE AS A MEMBER
Washington, DC (May 4, 2023) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today welcomed Capstone Health Alliance as a member of the association. Capstone has been a driving force in healthcare since 2000, providing purchasing advantages for organizations of all types and sizes.
Click here to read the full release.
Lear MoreHSCA Response to Senate Committee on Health, Education, Labor, and Pensions (HELP) RFI on the Pandemic and All-Hazards Preparedness Act (PAHPA)
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading
healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide the Senate
Health, Education, Labor, and Pensions (HELP) Committee with our recommendations on the
reauthorization of the Pandemic and All-Hazards Preparedness (PAHPA) Act.
Click here to read the full response.
Lear MoreHEALTHCARE SUPPLY CHAIN ASSOCIATION ANNOUNCES HSCA CONNECT AFFILIATE PROGRAM TO IMPROVE SUPPLY CHAIN PROCESSES ACROSS THE HEALTHCARE CONTINUUM
Washington, DC (March 21, 2023) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today announced HSCA Connect, its new affiliate program, intended for stakeholders from different areas of the healthcare continuum. The program is open to manufacturers (including pharma, medtech, med supplies, laboratories), distributors, and service providers (legal, consultants, finance, analysts). Applications are now open, and interested organizations are encouraged to apply by June 1, 2023, for first consideration.
Click here to read the full release.
Lear MoreHSCA Response to Congressional RFI on the Pandemic and All-Hazards Preparedness Act (PAHPA)
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to comment on the Pandemic and All-Hazards Preparedness Act (PAHPA) programs and authorities.
Click here to read the full response.
Lear MoreHSCA STATEMENT ON STATE OF THE UNION ADDRESS
Washington, DC (February 8, 2022) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today released the following statement from President and CEO Todd Ebert, R. Ph., regarding President Biden’s State of the Union address:
“HSCA and its member group purchasing organizations (GPOs) applaud President Biden’s commitment to bolstering domestic manufacturing and to ensuring that essential medications and healthcare products are both affordable and accessible. Healthcare GPOs play a critical role in maintaining a resilient supply chain, rapidly adding new and nontraditional U.S.-based suppliers to contracts to increase supply throughout the COVID-19 pandemic.”
“Expanding domestic manufacturing capabilities in all sectors, including healthcare, is essential to public health emergency and natural disaster preparedness efforts. As the U.S. transitions out of the public health emergency this spring, GPOs will continue to support America’s hospitals and healthcare providers by reducing supply costs while ensuring providers have access to the high-quality products and services they need to care for their patients.”
“We look forward to continued work with the Biden administration, bipartisan Members of Congress, and all healthcare stakeholders to safeguard patient care and to increase U.S. preparedness to combat future pandemics and other significant public health threats.”
Click here to view the full statement.
Lear MoreHSCA Comments on FDA Draft Guidance for Drug Supply Chain Security Act (DSCSA) Standards
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to comment on the U.S. Food and Drug Administration’s (FDA’s) revised draft guidance, “DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs Guidance for Industry.”
Click here to read the full comments.
Lear MoreHEALTHCARE SUPPLY CHAIN ASSOCIATION JOINS END DRUG SHORTAGE ALLIANCE TO SAFEGUARD ACCESS TO ESSENTIAL MEDICATIONS
Washington, DC (October 12, 2022) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today announced it has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of healthcare’s more pressing and enduring issues, drug shortages that disrupt patient care.
“Healthcare GPOs are critical partners helping hospitals and the healthcare system avert and mitigate the impact of drug shortages and have helped reduce the number of shortages by half over the last decade. The Healthcare Supply Chain Association is proud to join the End Drug Shortage Alliance alongside many of our member GPOs and looks forward to working with the coalition to identify durable solutions to drug shortages and protect patient access to care,” said HSCA President and CEO Todd Ebert.
The End Drug Shortages Alliance was launched in late 2021 to bring together industry stakeholders, including providers, group purchasing organizations, manufacturers, distributors, and other industry thought leaders and champions. Efforts will focus on improving access to medications through greater transparency across market participants, leading to improved quality manufacturing of medications and production of additional supply. Learn more at EndDrugShortages.com.
Click here to read the full release.
Lear More